{
    "clinical_study": {
        "@rank": "58664", 
        "acronym": "ROP patches", 
        "arm_group": [
            {
                "arm_group_label": "Eye patches covers", 
                "arm_group_type": "Experimental", 
                "description": "The infants were randomly assigned by alternating enrolled patients between one of two groups prior to their first ROP screening.  Group A was patched for their first ROP exam and then unpatched for their second exam while group B was unpatched for their first ROP exam and unpatched for their second exam.  The patched subjects had eye covers after their eyes were dilated, and the unpatched subjects had comfort measures similar to the patched subjects but their eyes were not covered.  The patching of the eyes was done in the same way that it is done for eye protection during phototherapy, with the same model of eye patches (Natus biliband) and with the same nursing care."
            }, 
            {
                "arm_group_label": "no eye patches covers", 
                "arm_group_type": "No Intervention", 
                "description": "The infants were randomly assigned by alternating enrolled patients between one of two groups prior to their first ROP screening.  Group A was patched for their first ROP exam and then unpatched for their second exam while group B was unpatched for their first ROP exam and unpatched for their second exam.  The patched subjects had eye covers after their eyes were dilated, and the unpatched subjects had comfort measures similar to the patched subjects but their eyes were not covered.  The patching of the eyes was done in the same way that it is done for eye protection during phototherapy, with the same model of eye patches (Natus biliband) and with the same nursing care."
            }
        ], 
        "brief_summary": {
            "textblock": "Pupillary dilation induced by mydriatic agents during Retinopathy of Prematurity exams can\n      persist for hours.  Despite regular use of eye protection for mydriatic-induced light\n      sensitivity for infants, children and adults, eye protection after mydriasis has not been\n      addressed in neonates.  This study examines the use of eye patches to protect the dilated\n      pupil from light exposure and their impact on vital signs and pain scores.   prevents\n      tachycardia, tachypnea and discomfort in neonates after ROP screening."
        }, 
        "brief_title": "\"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores\"", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": "Light Sensitivity", 
        "condition_browse": {
            "mesh_term": "Photophobia"
        }, 
        "detailed_description": {
            "textblock": "Pain management for Retinopathy of prematurity (ROP) screening focuses on pharmacological\n      and non-pharmacological interventions during the actual eye examination.  Management of pain\n      related to increased light sensitivity during the post-mydriasis period has not been\n      described.\n\n      This prospective, randomized study evaluated the impact of protecting the eyes from ambient\n      light exposure post mydriasis.  Vital signs and pain scales were recorded in infants\n      randomized to either wear or not wear eye patches after mydriasis for their ROP exam.\n      Infants less than 30 weeks gestational age or less than 1500 grams at birth were included.\n      Standard statistical methods were used to compare vital signs and pain scores for each group\n      at baseline, 1 and 3 hours after mydriasis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All infants with gestational age at birth of 30 weeks or less or with birth weight\n             less than 1500g undergoing their first ROP exam in the ISCU at UTMB.\n\n        Exclusion Criteria:\n\n          -  Infants were excluded if they had any congenital malformation or syndrome; a history\n             of eye surgery or were receiving inotropics medications."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "28", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860534", 
            "org_study_id": "IRB-11-039"
        }, 
        "intervention": {
            "arm_group_label": "Eye patches covers", 
            "description": "The infants were randomly assigned by alternating enrolled patients between one of two groups prior to their first ROP screening.  Group A was patched for their first ROP exam and then unpatched for their second exam while group B was unpatched for their first ROP exam and unpatched for their second exam.  The patched subjects had eye covers after their eyes were dilated, and the unpatched subjects had comfort measures similar to the patched subjects but their eyes were not covered.  The patching of the eyes was done in the same way that it is done for eye protection during phototherapy, with the same model of eye patches (Natus biliband) and with the same nursing care.", 
            "intervention_name": "eye covers", 
            "intervention_type": "Behavioral", 
            "other_name": "model of eye patches (Natus biliband) - routinely used for phototherapy eye protection"
        }, 
        "intervention_browse": {
            "mesh_term": "Mydriatics"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pain", 
            "mydriasis", 
            "light"
        ], 
        "lastchanged_date": "May 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Galveston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77555"
                }, 
                "name": "University of Texas Medical Branch"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "\"Eye Protection After Mydriatic Use for ROP Screening: Impact on Vitals Signs and Pain Scores\"", 
        "overall_official": {
            "affiliation": "UTMB", 
            "last_name": "Erika M. Espino-Torres, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "At 3 times (pre-mydriasis, 1 hour and 3 hours after Cyclomydril drops), subjects were exposed to ambient lighting for a period of five minutes.  This usually entailed removing isolette covers and exposing the patient to the ambient room light.  During this time, pain and vital signs were recorded every minute. Heart rate was recorded directly from their cardio-respiratory monitor (Agilent M1106C).  The mean of the five recorded values for each variable was used", 
            "measure": "Heart Rate", 
            "safety_issue": "No", 
            "time_frame": "pre-mydriasis, 1 hour and 3 hours after mydriatic drops"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860534"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of Texas, Galveston", 
            "investigator_full_name": "Erkia Espino-Torres", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "At 3 times (pre-mydriasis, 1 hour and 3 hours after Cyclomydril drops), subjects were exposed to ambient lighting for a period of five minutes.  This usually entailed removing isolette covers and exposing the patient to the ambient room light.  During this time, pain and vital signs were recorded every minute. Respiratory rate was recorded directly from their cardio-respiratory monitor (Agilent M1106C).  The mean of the five recorded values for each variable was used", 
                "measure": "Respiratory rate", 
                "safety_issue": "No", 
                "time_frame": "pre-mydriasis, 1 hour and 3 hours after mydriatic drops"
            }, 
            {
                "description": "At 3 times (pre-mydriasis, 1 hour and 3 hours after Cyclomydril drops), subjects were exposed to ambient lighting for a period of five minutes.  This usually entailed removing isolette covers and exposing the patient to the ambient room light.  During this time, pain and vital signs were recorded every minute. Oxygen saturation was recorded directly from their cardio-respiratory monitor (Agilent M1106C).  The mean of the five recorded values for each variable was used", 
                "measure": "Oxygen saturation", 
                "safety_issue": "No", 
                "time_frame": "pre-mydriasis, 1 hour and 3 hours after mydriatic drops"
            }, 
            {
                "description": "At 3 times (pre-mydriasis, 1 hour and 3 hours after Cyclomydril drops), subjects were exposed to ambient lighting for a period of five minutes.  This usually entailed removing isolette covers and exposing the patient to the ambient room light.  During this time, pain and vital signs were recorded every minute. Pain scores were recorded by direct observation using the Neonatal and Infant Pain Scale (NIPS).  The mean of the five recorded values for each variable was used", 
                "measure": "Pain", 
                "safety_issue": "No", 
                "time_frame": "pre-mydriasis, 1 hour and 3 hours after mydriatic drops"
            }
        ], 
        "source": "The University of Texas, Galveston", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of Texas, Galveston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}